Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000402059

Medchemexpress LLC YK-3-237 | 1215281-19-8 | 99.5% | 372.18 | 50 MG
SDP

Catalog No. 5000402059
Encompass_Preferred

YK-3-237 is a SIRT1 activator that targets mutant p53 and inhibits the proliferation of triple-negative breast cancer cells. This compound offers a potent and selective approach to cancer research with several key activities:

  • Exhibits anti-proliferative activities toward most breast cancer cell lines at submicromolar concentration.
  • Preferentially inhibits the proliferation of breast cancer cell lines carrying mtp53.
  • Inhibits the proliferation of triple-negative breast cancer (TNBC) cell lines.
  • Deacetylates mtp53 in TNBC cell lines.
  • Potent activator of Sirt1.

Catalog No. 50-004-02059 Supplier Medchemexpress LLC Supplier No. HY1963450MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

YK-3-237 is a SIRT1 activator that targets mutant p53 and inhibits the proliferation of triple-negative breast cancer cells. This compound offers a potent and selective approach to cancer research with several key activities:

  • Exhibits anti-proliferative activities toward most breast cancer cell lines at submicromolar concentration.
  • Preferentially inhibits the proliferation of breast cancer cell lines carrying mtp53.
  • Inhibits the proliferation of triple-negative breast cancer (TNBC) cell lines.
  • Deacetylates mtp53 in TNBC cell lines.
  • Potent activator of Sirt1.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.